ask="5.59"
ask_size="300"
average_daily_volume="1425220"
bid="4.00"
bid_size="200"
book_value="-0.08"
change="+0.14"
change_from_200_day_moving_average="0.27"
change_from_50_day_moving_average="0.42"
change_from_52_week_high="-2.24"
change_From_52_week_low="1.57"
change_in_percent="+2.58%"
close="5.56"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.52"
ebitda="-121.76M"
eps_estimate_current_year="-0.67"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="72994000"
high="5.56"
high_52_weeks="7.80"
last_trade_date="3/13/2017"
last_trade_price="5.56"
last_trade_size="35850"
last_trade_time="4:00pm"
low="5.29"
low_52_weeks="3.99"
market_capitalization="598.63M"
moving_average_200_day="5.29"
moving_average_50_day="5.14"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="5.38"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+5.05%"
percent_change_from_50_day_moving_average="+8.27%"
percent_change_from_52_week_high="-28.72%"
percent_change_from_52_week_low="+39.35%"
previous_close="5.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="18.25"
revenue="31.98M"
shares_outstanding="107667000"
short_ratio="14.93"
stock_exchange="NCM"
symbol="KERX"
volume="1214231"
weeks_range_52="3.99 - 7.80"
